Status:

RECRUITING

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

Lead Sponsor:

Abbott Medical Devices

Conditions:

Movement Disorders

Parkinson Disease

Eligibility:

All Genders

Brief Summary

The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential t...

Detailed Description

ADROIT is an international, prospective, multicenter, observational, post-market study intended to collect worldwide long-term safety and effectiveness data on subjects implanted with market-released ...

Eligibility Criteria

Inclusion

  • Subject is scheduled for a new implant or IPG device replacement surgery with a market-released Abbott DBS system within 180 days.
  • Subject, or a legally acceptable representative, must provide written informed consent prior to any study-related procedure.

Exclusion

  • Subject is currently enrolled or plans to enroll in an investigational study that may confound the results of this study.
  • Subject has anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the study or to comply with follow-up requirements, or impact the scientific soundness of the study results.
  • Study center is located in the United States, and indication for DBS implant is not Parkinson's disease or disabling tremor.
  • Study center is located in the United States, and the intended lead implant location is not at, or in close proximity to, the STN, GPi, or VIM thalamus.

Key Trial Info

Start Date :

November 26 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2030

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT04071847

Start Date

November 26 2019

End Date

September 1 2030

Last Update

January 8 2026

Active Locations (48)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 12 (48 locations)

1

University of Aizona Health Sciences

Tucson, Arizona, United States, 85274

2

Cedars-Sinai Medical Center

Los Angeles, California, United States, 90048

3

University of California at Davis

Sacramento, California, United States, 95817

4

Colorado Neurodiagnostics

Littleton, Colorado, United States, 80120